Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis

被引:73
作者
Colling, Meaghan E. [1 ,2 ]
Bendapudi, Pavan K. [2 ,3 ,4 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Hematol, Yawkey 7B,55 Fruit St, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA
关键词
Purpura fulminans; Disseminated intravascular coagulation; Acquired protein C deficiency; Sepsis; ACTIVATED PROTEIN-C; DISSEMINATED INTRAVASCULAR COAGULATION; RANDOMIZED CONTROLLED-TRIAL; SEPTIC SHOCK; DROTRECOGIN-ALPHA; SEVERE SEPSIS; MENINGOCOCCAL PURPURA; ANTICOAGULANT ACTIVITY; ANTITHROMBIN-III; HEPARIN;
D O I
10.1016/j.tmrv.2017.10.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpura fulminans (PF) is a highly thrombotic subtype of disseminated intravascular coagulation that can accompany severe bacterial, and more rarely, viral infections. PF is associated with an extremely high mortality rate, and patients often die of overwhelming multisystemic thrombosis rather than septic shock. Survivors typically experience amputation of involved extremities and significant scarring in affected areas. Despite the devastating clinical course associated with this hemostatic complication of infection, the mechanism of PF remains poorly understood. Severe acquired deficiency of protein C and dysfunction of the protein C-thrombomodulin pathway as well as other systems that exert a negative regulatory effect on coagulation have been implicated. Management of PF involves treatment of the underlying infection, aggressive anticoagulation, and robust transfusion support aimed at correcting acquired deficiencies in natural anticoagulant proteins. In this review, we address the diagnosis and management of PF with a focus on a rational approach to this condition informed by the available data. Proposed mechanisms underlying the dysregulation of coagulation seen in PF are also covered, and implications for therapy are discussed. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 87 条
[1]   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death [J].
Abraham, E ;
Laterre, P ;
Garg, R ;
Levy, H ;
Talwar, D ;
Trzaskoma, BL ;
Francois, B ;
Guy, JS ;
Bruckmann, M ;
Rea-Neto, A ;
Rossaint, R ;
Perrotin, D ;
Sablotzki, A ;
Arkins, N ;
Utterback, BG ;
Macias, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1332-1341
[2]   DERMATOPATHOLOGY OF SKIN NECROSIS ASSOCIATED WITH PURPURA FULMINANS [J].
ADCOCK, DM ;
HICKS, MJ .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1990, 16 (04) :283-292
[3]   Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar [J].
Aisiku, Omozuanvbo ;
Peters, Christian G. ;
De Ceunynck, Karen ;
Ghosh, Chandra C. ;
Dilks, James R. ;
Fustolo-Gunnink, Susanna F. ;
Huang, Mingdong ;
Dockendorff, Chris ;
Parikh, Samir M. ;
Flaumenhaft, Robert .
BLOOD, 2015, 125 (12) :1976-1985
[4]   Recombinant Human Activated Protein C for Adults with Septic Shock A Randomized Controlled Trial [J].
Annane, Djillali ;
Timsit, Jean-Francois ;
Megarbane, Bruno ;
Martin, Claude ;
Misset, Benoit ;
Mourvillier, Bruno ;
Siami, Shidasp ;
Chagnon, Jean-Luc ;
Constantin, Jean-Michel ;
Petitpas, Franck ;
Souweine, Bertrand ;
Amathieu, Roland ;
Forceville, Xavier ;
Charpentier, Claire ;
Tesniere, Antoine ;
Chastre, Jean ;
Bohe, Julien ;
Colin, Gwenhael ;
Cariou, Alain ;
Renault, Alain ;
Brun-Buisson, Christian ;
Bellissant, Eric .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (10) :1091-1097
[5]   SEQUENTIAL COAGULATION STUDIES IN PURPURA FULMINANS [J].
ANTLEY, RM ;
MCMILLAN, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (23) :1287-&
[6]   Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans [J].
Bachli, EB ;
Vavricka, SR ;
Walter, RB ;
Leschinger, MI ;
Maggiorini, M .
INTENSIVE CARE MEDICINE, 2003, 29 (02) :337-337
[7]  
Belloni G, 2006, MINERVA ANESTESIOL, V72, P249
[8]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[9]   Purpura fulminans in sepsis [J].
Betrosian, Alex P. ;
Berlet, Tom ;
Agarwal, Banwari .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 332 (06) :339-345
[10]   MENINGOCOCCAL SEPTICEMIA TREATED WITH COMBINED PLASMAPHERESIS AND LEUKAPHERESIS OR WITH BLOOD-EXCHANGE [J].
BJORVATN, B ;
BJERTNAES, L ;
FADNES, HO ;
FLAEGSTAD, T ;
GUTTEBERG, TJ ;
KRISTIANSEN, BE ;
PAPE, J ;
REKVIG, OP ;
OSTERUD, B ;
AANDERUD, L .
BMJ-BRITISH MEDICAL JOURNAL, 1984, 288 (6415) :439-441